查看完整行情页>>

|

货币单位:美元(USD)

BioLife Solutions, Inc. (blfs)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Brett Stucker Brett Stucker currently works at BioLife Solutions, Inc., as VP-Cybersecurity & Head-Information Security.
Aby J. Mathew Aby J. Mathew is the founder of BioLife Solutions, Inc. (founded in 1998) and currently holds the position of Chief Scientific Officer & Executive VP. Dr. Mathew is also currently serving as a Director at the National Institute of Standards & Technology, California Institute for Regenerative Medicine, PanTHERA CryoSolution, Inc., and Parents Guide To Cord Blood Foundation, Inc. Dr. Mathew previously worked as a Director at the Cord Blood Association and held membership positions at various organizations including the American Association of Blood Banks, International Society for Cellular Therapy, The American Society for Cell Biology, The Society for in Vitro Biology, International Society for Biological & Environmental Reposit, Society of Cryobiology, Alliance for Regenerative Medicine, Tissue Engineering & Generative Medicine International Society, and Biomedical Excellence For Safer Transfusion Collaborative. Dr. Mathew completed undergraduate studies at Cornell University and obtained a doctorate degree from the State University of New York at Binghamton.
Todd Berard Todd Berard is currently the Chief Marketing Officer at BioLife Solutions, Inc. He previously worked as the Marketing Director at Verathon Medical, Inc. Mr. Berard received his undergraduate degree from the University of Vermont and his MBA from the Michael G. Foster School of Business.
Karen Foster Karen Foster is currently the Chief Quality & Operations Officer at BioLife Solutions, Inc. She previously worked as the Vice President-Laboratory Operations at ViaCord LLC from 2003 to 2016. Ms. Foster completed her undergraduate degree at Michigan Technological University and holds a graduate degree, as well as an MBA, from the University of Wisconsin-Milwaukee.
Garrie Richardson Garrie Richardson is the founder of SciSafe, Inc., which was founded in 2010. He currently holds the position of President at SciSafe, Inc. Additionally, Mr. Richardson is currently working as the Chief Revenue Officer at BioLife Solutions, Inc. since 2023.
Marcus Schulz Presently, Marcus Schulz is Chief Revenue Officer for BioLife Solutions, Inc. In his past career Mr. Schulz was Executive Director-Healthcare Improvement at Abbott Laboratories, Sales Director at Johnson & Johnson, Director-Strategic National Account at Siemens Medical Solutions USA, Inc., Executive Director-Strategic Solutions Group at Belimed AG, Director-Business Development at Aramark Healthcare Technologies LLC and General Manager-National Accounts at GE Healthcare, Inc.
Sarah Aebersold Sarah Aebersold currently works at BioLife Solutions, Inc., as Chief Human Resources Officer from 2023. Ms. Aebersold also formerly worked at T-Mobile USA, Inc., as Human Resource Manager in 2013, ZymoGenetics, Inc., as Human Resources Manager from 2004 to 2009, Spacelabs Healthcare, Inc., as Senior Manager-Human Resources from 2012 to 2016, Seattle Children's Hospital, as Manager-Human Resources Consulting from 2009 to 2012, and MCG Health LLC, as Head-Human Resources & Administration from 2016 to 2020. Ms. Aebersold received her graduate degree from Seattle University.
Troy Wichterman Troy Wichterman is currently working as the CFO, Head-Media & Investor Relations at BioLife Solutions, Inc. He started this position in 2021. Previously, he worked as a Senior Financial Analyst-Acquisitions at Ventas, Inc. from 2013 to 2014, and as an Associate Auditor at PricewaterhouseCoopers LLP from 2008 to 2009. Mr. Wichterman completed his undergraduate and graduate degrees at the University of Wisconsin.
Geraint Phillips Geraint Phillips is currently the Senior Vice President-Global Operations at BioLife Solutions, Inc. He previously worked as the Senior Director-BioRepository Operations at Azenta US, Inc. from 2019 to 2020, the Vice President-Global Operations at Revvity, Inc. from 2007 to 2016, the Chief Operations Officer at Global Cooling, Inc. from 2020 to 2021, and the Vice President-Global Operations at Humanscale Corp. from 2016 to 2019. He obtained an undergraduate degree from the University of Cardiff and an MBA from the University of South Wales.
Roderick de Greef Roderick de Greef is currently the Executive Chairman & Chief Executive Officer at BioLife Solutions, Inc., the Director at Upper Connecticut Valley Hospital Association, the Chief Financial Officer & Director at Realanalogics, Inc., the Director at Sirona Medical Technologies, Inc., and the Principal at Taveyanne Capital Advisors, Inc. Previously, Mr. de Greef held positions such as Chairman, President & Treasurer at Cambridge Heart, Inc., Independent Director at BioLife Solutions, Inc., Independent Director at Endologix LLC, Independent Director at Pareteum Corp., Director at Pareteum Corp., Director at Genesis Biosciences, Inc., President & Director at Cambridge Cardiac Technologies, Inc., Independent Director at Indonesia Energy Corp. Ltd., Chief Financial Officer & Executive Vice President at Cardiac Science, Inc., CFO & Vice President-Administration at Cambridge Heart, Inc., Chief Financial Officer at CardioPolymers, Inc., Chief Financial Officer & Vice President at BioAnalogics, Inc., Chief Financial Officer & Vice President at International BioAnalogics, Inc., Chief Financial Officer at Brentwood Instruments, Inc., and Partner at Medtech Advisors, Inc.Mr. de Greef obtained an undergraduate degree from San Francisco State University in 1983 and an MBA from the University of Oregon in 1993.
Rachel H. Ellingson Rachel H. Ellingson is currently the Vice Chairman at LifeScience Alley since 2015. She is also an Independent Director at BioLife Solutions, Inc. since 2021. Additionally, she holds the position of Director at the American Heart Association, Inc. Rachel's former positions include being the Chief Strategy Officer & Senior Vice President at Zimmer Biomet Holdings, Inc. starting in 2018. She was also the President of St. Jude Medical Foundation. Prior to her current and former roles, Rachel worked as an MD-Medical Technology Investment Banking at Bank of America Corp. She was the Vice President-Corporate Strategy at St. Jude Medical LLC from 2016 to 2017. Rachel also served as the VP-Business Development & Investor Relations at AGA Medical Holdings, Inc. and AGA Medical Corp. from 2009 to 2011. Ms. Ellingson completed her undergraduate degree at the University of Rhode Island and holds an MBA from the University of Connecticut.
Joseph Schick Joseph Schick is currently the Director at Branded Entertainment Network Holdings, Inc., the Independent Director at BioLife Solutions, Inc., and the Chief Financial Officer at Corporation of the Catholic Archbishop of Seattle. Previously, he held positions such as Co-Managing Director at BEN Branded Entertainment Network GmbH, Principal at Starwood Hotels & Resorts Worldwide LLC, Senior Vice President-Finance at Expedia Group, Inc., Principal at Hewitt Associates, Inc., Principal at Arthur Andersen LLP, Principal at Westin Hotels & Resorts Worldwide, Inc., Chief Financial Officer at Branded Entertainment Network, Inc., Controller at Humongous Entertainment, Inc., Chief Financial Officer at Vertafore, Inc., and Chief Financial Officer at Verity Solutions Group, Inc. Mr. Schick completed his undergraduate degree at the University of Illinois.
Timothy L. Moore Timothy L. Moore is currently serving as the Independent Director at BioLife Solutions, Inc. since 2022 and at Cerus Corp. since 2018. He is also a Member of the International Society for Pharmaceutical Engineering and the Parenteral Drug Association. In 2023, he will assume the role of Chief Technical Officer & Executive Vice President at Allogene Therapeutics, Inc. Previously, Mr. Moore held positions as the Independent Non-Executive Director at Cognate BioServices, Inc., Director at Fusionkite, Senior Vice President-Global Supply Chain at Genentech, Inc. from 2004 to 2010, Vice President-Operations at Aventis Behring from 2000 to 2004, and Vice President-Operations at CSL Behring LLC. He also served as the Executive Vice President-Technical Operations at Kite Pharma, Inc. from 2016 to 2019 and as the President, Chief Operating & Technical Officer at PACT Pharma, Inc. Mr. Moore's education includes a graduate degree from Northwestern University and an undergraduate degree from The University of Tulsa.
Joydeep Goswami Joydeep Goswami is an Independent Director at BioLife Solutions, Inc. He is also a Director at TMune Therapeutics, Inc., OncoNano Medicine, Inc., and Life Technologies Japan Ltd. Previously, he served as a Director at Q Therapeutic Products, Inc. and Q Therapeutics, Inc. He was also the VP-Stem Cell & Regenerative Biology at Invitrogen Corp. and a Principal at McKinsey & Co., Inc. From 2016 to 2019, he was the President-Clinical Next Generation. Sequencing at Thermo Fisher Scientific, Inc. He has also held positions as Vice President at Life Technologies Corp. and CFO, Chief Strategy & Development Officer at Illumina, Inc. His education includes a graduate degree, MBA, and a doctorate from the Massachusetts Institute of Technology, as well as an undergraduate degree from the Indian Institute of Technology Bombay. Dr. Goswami's current job(s) include being an Independent Director at BioLife Solutions, Inc.
Amy DuRoss Amy DuRoss was the founder of Vineti, Inc. (founded in 2016) where she held the title of Chief Executive Officer & Director from 2016 to 2022. She has also held the following current positions: Lead Independent Director at BioLife Solutions, Inc. since 2021, Director at Arm Foundation since 2019, Senior Advisor at Frazier Management LLC since 2022, and President at Doubleday Acquisitions LLC. In her former positions, she was the Managing Director at GE Ventures LLC from 2013 to 2017, and held various roles including Principal at E-LOAN, Inc., First Data Government Solutions LP, The World Bank Group, California Institute for Regenerative Medicine, and Life Technologies Clinical Services Lab, Inc. Ms. DuRoss completed her undergraduate degree and MBA at Stanford University.